Exelon analysts trim targets ahead of Tuesday earnings
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
EXC heads into its October 28 results with a coordinated wave of analyst target cuts behind it and a stock that has, so far, absorbed the downgrades without much damage.
The target reductions came quickly. Morgan Stanley cut its price objective to $49 from $50 on Tuesday. JP Morgan moved to $46 from $47 on Monday. Barclays made the sharpest move of the group, dropping its target to $44 from $49. Truist Securities lowered to $46 from $48 the week prior. None of these firms changed their ratings, all remain at Hold or Equal-Weight equivalents, but the compression in targets is consistent: Morgan Stanley has now trimmed three times since August, taking its objective from $55 to $49 in two months. The one counterweight was Keybanc, which upgraded EXC from Underweight to Sector Weight on October 13, though without attaching a price target. The Street's consensus mean now stands at $48.38, about 12% above the current price of $43.03, implying there is nominal upside on paper even after the cuts.
The bull case rests on Exelon's transmission footprint, which commands a FERC return on equity near 10.5%, and on year-over-year earnings improvement at ComEd, where regulatory timing and distribution assets have added to results. Bears point to the rate case risk inherent in all regulated utilities: if outcomes disappoint, there is limited room to recover through growth investment, given that the capital expenditure trajectory is already running below prior guidance levels. At a trailing P/E of 14.3x and EV/EBITDA of 9.2x, the valuation has drifted modestly higher over the past month. The dividend factor score ranks in the 92nd percentile across the ORTEX universe, reflecting EXC's position as a yield-oriented holding. EPS momentum scores are softer, ranking in the high 30s on both the 30-day and 90-day measures, and EPS surprise sits at the 40th percentile, suggesting the company is not a habitual beater.
Short positioning carries no meaningful signal here. Short interest has fallen roughly 3% over the past month to 3.1% of free float, a level too low to generate squeeze dynamics or mark a directional view. The borrow market is also unremarkable: cost to borrow ticked up to 0.60% this week, 11% above the prior week's level, but remains firmly in the "low" category by any historical standard. Availability is exceptionally loose, with more than 2,600% of current short interest available to borrow, well above the 52-week floor of 723%. Options positioning is equally quiet, with the put/call ratio at 0.57, fractionally below the 20-day average of 0.59 and not at any extreme within the past year.
The stock has moved in a tight range with its peers this week. EXC gained 1.6% over the past five days, slightly ahead of DUK at 2.7% and SO at 3.0%, but consistent with the broader sector tone rather than breaking from it. The one piece of alternative data worth noting: Wikipedia page views for Exelon generated a retail attention z-score of 2.1 relative to the company's own 90-day history, measured as of late September. The reading reflects above-average retail interest, though it carries no demonstrated link to the company's financial figures.
What matters next is the October 28 earnings release. The prior two prints produced day-one declines of 2.6% and 3.7% respectively, with five-day moves also negative both times. Whether the latest round of analyst target cuts front-runs any weakness in the numbers, or simply reflects rate and macro caution, is the specific question the quarter's figures will answer.
Stocks in this article
See the live data behind this article on ORTEX.
Open EXC on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 18:25
- Data as of
- 21 Oct 2026, 18:16
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.